» Articles » PMID: 33960582

Exploring the Acceptance of COVID-19 Vaccine Among Healthcare Workers and General Population Using Health Belief Model

Overview
Date 2021 May 7
PMID 33960582
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale, Aims And Objectives: Little is known about hesitancy to receive the COVID-19 vaccines. The objectives of this study were (1) to assess the perceptions of healthcare workers (HCWs) and the general population regarding the COVID-19 vaccines, (2) to evaluate factors influencing the acceptance of vaccination using the health belief model (HBM), and (3) to qualitatively explore the suggested intervention strategies to promote the vaccination.

Methods: This was a cross-sectional study based on electronic survey data that was collected in Iraq during December first-19th, 2020. The electronic survey was designed using Qualtrics. HBM was followed to develop the survey items. A regression analysis was used to identify factors influencing people accepting vaccination. Thematic analysis for participant comments to an open-ended question.

Results: A total of 1680 completed surveys were received. The mean age of 31.2 ± 9.9 years, 53.0% were female and 47.0% were male. The largest group was HCWs (45.7%), followed by general population (37.5%) and health college students (16.8%). Our findings expressed some hesitancy to receive the COVID-19 vaccine with the acceptance rate of 61.7%. The HCWs perceived significantly higher susceptibility and severity of the COVID-19 infection compared to the general population. The HCWs were significantly more likely than the general population to receive COVID-19 vaccine. Concerns with proper storage was the biggest barrier to vaccine receipt. The regression analysis indicated eight factors that were significantly associated with the willingness to receive COVID-19 vaccine: Preventive measures, perceived benefit, perceived barriers, cue to action, subjective norm, supportive of vaccination in general and having received a flu vaccine before.

Conclusions: Awareness campaign can focus on enhancing the vaccine perceived benefit, debunking misconceptions, and increasing the disease perceived severity. Additionally, the public health leaders need to minimize the perceived barriers by providing the vaccines and appeasing people concerns about their storage, effectiveness, and adverse events.

Citing Articles

Delving into the Elements Impacting Treatment Acceptance among patients with Substance Use Disorder using Health Belief Model: a qualitative study.

Muslim S, Al-Jumaili A, Al-Ani H BMC Psychol. 2025; 13(1):177.

PMID: 40022272 PMC: 11871802. DOI: 10.1186/s40359-025-02469-7.


Psychometric Analysis of Items Evaluating Health Belief Model Constructs in Social Media Posts: Application of Rasch Measurement Model.

Jia X, Ahn S Behav Sci (Basel). 2025; 15(2).

PMID: 40001834 PMC: 11851386. DOI: 10.3390/bs15020204.


Impact of perceived factors of coronavirus infection on COVID-19 vaccine uptake among healthcare workers in Ghana-Evidence from a cross-sectional analysis.

Gelyi E, Azaare J, Bonso N, Kpordoxah M, Aninanya G PLoS One. 2025; 20(2):e0318662.

PMID: 39937845 PMC: 11819584. DOI: 10.1371/journal.pone.0318662.


Exploring Breastfeeding Mothers' and Lactation Consultants' Experiences of Lactation Consultancy Throughout the Restrictions Put in Place Due to the COVID-19 Pandemic.

Connolly A, Matthews A HRB Open Res. 2025; 7:9.

PMID: 39866371 PMC: 11757925. DOI: 10.12688/hrbopenres.13856.2.


Influenza vaccine hesitancy and its determinants among Lebanese public transportation drivers.

Salam M, Haidar G Vaccine X. 2025; 22():100606.

PMID: 39845631 PMC: 11750564. DOI: 10.1016/j.jvacx.2024.100606.


References
1.
Wise J . Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021; 372:n699. DOI: 10.1136/bmj.n699. View

2.
Fisher K, Bloomstone S, Walder J, Crawford S, Fouayzi H, Mazor K . Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020; 173(12):964-973. PMC: 7505019. DOI: 10.7326/M20-3569. View

3.
Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

4.
Cummings K, Jette A, Rosenstock I . Construct validation of the health belief model. Health Educ Monogr. 1978; 6(4):394-405. DOI: 10.1177/109019817800600406. View

5.
Mikhael E, Al-Jumaili A . Can developing countries face novel coronavirus outbreak alone? The Iraqi situation. Public Health Pract (Oxf). 2021; 1:100004. PMC: 7194717. DOI: 10.1016/j.puhip.2020.100004. View